Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 35 | 42 | 35 | 83 | 1 |
| Cost of Goods | 42 | 38 | 36 | 78 | N/A |
| Gross Profit | -7 | 4 | -1 | 5 | 1 |
| Operating Expenses | 3,307 | 3,868 | 3,516 | 3,308 | 3,141 |
| Operating Income | -3,272 | -3,826 | -3,481 | -3,225 | -3,140 |
| Interest Expense | 302 | 0 | 0 | 0 | 0 |
| Other Income | 53 | -262 | 64 | 35 | 64 |
| Pre-tax Income | -3,521 | -4,088 | -3,417 | -3,190 | -3,076 |
| Net Income Continuous | -3,521 | -4,088 | -3,417 | -3,190 | -3,076 |
| Net Income | $-3,521 | $-4,088 | $-3,417 | $-3,190 | $-3,076 |
| EPS Basic Total Ops | -0.35 | -0.40 | -0.30 | -0.35 | -0.35 |
| EPS Basic Continuous Ops | -0.36 | -0.42 | -0.34 | -0.34 | -0.33 |
| EPS Diluted Total Ops | -0.35 | -0.40 | -0.30 | -0.35 | -0.35 |
| EPS Diluted Continuous Ops | -0.36 | -0.42 | -0.34 | -0.34 | -0.33 |
| EBITDA(a) | $-3,133 | $-3,676 | $-3,451 | $-3,190 | $-3,105 |